Yao Hui-Ping, Wang Ya-Nuo, Chen Yan-Wei, Gao Sha, Zhong Yi-Sheng, Shen Xi
Department of Ophthalmology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Int J Ophthalmol. 2025 Sep 18;18(9):1665-1672. doi: 10.18240/ijo.2025.09.07. eCollection 2025.
To present a case series of rapid-onset neovascular glaucoma (NVG) accompanied by vitreous haemorrhage (VH) following cataract surgery in diabetic patients, and to evaluate the efficacy of pars plana vitrectomy (PPV) combined with Ahmed glaucoma valve (AGV) implantation.
This is a retrospective, single-center, consecutive case series. All patients underwent 23-gauge PPV with AGV implantation 2-3d after intravitreal ranibizumab injection (IVR). The minimum postoperative follow-up period lasted 12mo. The primary outcome measures included best-corrected visual acuity (BCVA), intraocular pressure (IOP), and topical hypotensive medications.
Fifteen diabetic patients (age, 46-81y) with rapid-onset NVG and VH following uncomplicated phacoemulsification were included. The median time to the initial NVG diagnosis following cataract surgery was within 4wk. After PPV combined with AGV implantation, the mean BCVA (logMAR) improved from 1.9 (range: 1.0 to 2.6) preoperatively to 1.2 (range: 0.2 to 2.6) at the final follow-up. Baseline BCVA and the presence of diabetic nephropathy (DN) were significantly associated with the final BCVA in the multiple regression model. The mean postoperative IOP at all follow-up visits was significantly reduced compared to baseline. At the final follow-up, 9 patients required one or two topical ocular hypotensive medications, while the other 6 needed not. Success was achieved in 87%, and the reoperation rate was 20%. The majority of NVG cases (9/15) were primarily attributed to the rapid progression of proliferative diabetic retinopathy. However, a notable subset (6 eyes) was complicated retinal vein occlusion or carotid artery occlusion.
PPV combined with AGV implantation after adjuvant IVR for rapid-onset NVG with VH following diabetic cataract surgery is one of the safe and effective treatments. Baseline BCVA and preexisting DN may be potential indicators for visual outcomes.
介绍一系列糖尿病患者白内障手术后出现的伴有玻璃体积血(VH)的快速进展性新生血管性青光眼(NVG)病例,并评估玻璃体切割术(PPV)联合艾哈迈德青光眼阀(AGV)植入术的疗效。
这是一项回顾性、单中心、连续病例系列研究。所有患者在玻璃体内注射雷珠单抗(IVR)后2 - 3天接受23G PPV联合AGV植入术。术后最短随访期为12个月。主要观察指标包括最佳矫正视力(BCVA)、眼压(IOP)和局部降眼压药物。
纳入15例糖尿病患者(年龄46 - 81岁),这些患者在单纯白内障超声乳化术后出现快速进展性NVG和VH。白内障手术后至首次诊断NVG的中位时间在4周内。PPV联合AGV植入术后,末次随访时平均BCVA(logMAR)从术前的1.9(范围:1.0至2.6)提高到1.2(范围:0.2至2.6)。在多元回归模型中,基线BCVA和糖尿病肾病(DN)的存在与末次随访时的BCVA显著相关。与基线相比,所有随访时的术后平均IOP均显著降低。在末次随访时,9例患者需要一种或两种局部眼部降眼压药物,而另外6例则不需要。成功率为87%,再次手术率为20%。大多数NVG病例(9/15)主要归因于增殖性糖尿病视网膜病变的快速进展。然而,有一个显著的亚组(6只眼)合并视网膜静脉阻塞或颈动脉阻塞。
糖尿病性白内障手术后快速进展性NVG伴VH患者,在辅助IVR后行PPV联合AGV植入术是安全有效的治疗方法之一。基线BCVA和既往DN可能是视力预后的潜在指标。